A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic-assisted Gastrectomy in Early Gastric Cancer Patients
Phase of Trial: Phase II
Latest Information Update: 31 May 2017
At a glance
- Drugs VVZ 149 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Vivozon
- 28 Sep 2016 Status changed from recruiting to completed.
- 02 Feb 2016 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 21 Aug 2015 New trial record